Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights
Basel, Switzerland – 28, January 2025 – Lyfegen, a global innovator in drug market access, pricing, and rebate management, has…
Basel, Switzerland – 28, January 2025 – Lyfegen, a global innovator in drug market access, pricing, and rebate management, has…
CHICAGO, IL (October 10, 2024) – EVERSANA, a leading provider of global commercialization services to the life sciences industry, today…